Amber Vander Kooi

Research Scientist
Seattle Children's Research Institute
Seattle, Washington, United States

Presentation(s):

• PB0248 - Reduced immunogenicity of FVIII through O-Glycopeptide Integration

  Sunday, June 23, 2024
  13:45 – 14:45 ICT